GB0623381D0 - Use of a compound as VEGF inhibitor - Google Patents
Use of a compound as VEGF inhibitorInfo
- Publication number
- GB0623381D0 GB0623381D0 GBGB0623381.1A GB0623381A GB0623381D0 GB 0623381 D0 GB0623381 D0 GB 0623381D0 GB 0623381 A GB0623381 A GB 0623381A GB 0623381 D0 GB0623381 D0 GB 0623381D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- compound
- vegf inhibitor
- vegf
- inhibitor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 150000001875 compounds Chemical class 0.000 title 1
- 239000002525 vasculotropin inhibitor Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0623381.1A GB0623381D0 (en) | 2006-11-23 | 2006-11-23 | Use of a compound as VEGF inhibitor |
| PCT/EP2007/009767 WO2008061647A1 (en) | 2006-11-23 | 2007-11-12 | Use of a compound as vegf inhibitor |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0623381.1A GB0623381D0 (en) | 2006-11-23 | 2006-11-23 | Use of a compound as VEGF inhibitor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB0623381D0 true GB0623381D0 (en) | 2007-01-03 |
Family
ID=37636386
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB0623381.1A Ceased GB0623381D0 (en) | 2006-11-23 | 2006-11-23 | Use of a compound as VEGF inhibitor |
Country Status (2)
| Country | Link |
|---|---|
| GB (1) | GB0623381D0 (en) |
| WO (1) | WO2008061647A1 (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010108503A1 (en) | 2009-03-24 | 2010-09-30 | Life & Brain Gmbh | Promotion of neuronal integration in neural stem cell grafts |
| AU2010277356A1 (en) * | 2009-07-31 | 2012-03-08 | Anamar Ab | Compounds for treatment of inflammation |
| DK3164123T3 (en) | 2014-07-02 | 2020-08-03 | Inflectis Bioscience | Novel uses of benzylideneguanidine derivatives in the treatment of proteopathies |
| JP6621815B2 (en) * | 2014-07-02 | 2019-12-18 | インフレクティス・バイオサイエンス | O-alkyl-benzylideneguanidine derivatives and therapeutic uses for the treatment of disorders associated with the accumulation of misfolded proteins |
| EP3790539A1 (en) | 2018-05-09 | 2021-03-17 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Use of guanabenz or derivates thereof for the treatment of type i ifn-dependent pathologies |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5599984A (en) * | 1994-01-21 | 1997-02-04 | The Picower Institute For Medical Research | Guanylhydrazones and their use to treat inflammatory conditions |
| SE9604348D0 (en) * | 1996-11-26 | 1996-11-26 | Wapharm Ab | Use of hydroxyguanidines |
| GB0019357D0 (en) * | 2000-08-07 | 2000-09-27 | Melacure Therapeutics Ab | Novel phenyl guanidines |
-
2006
- 2006-11-23 GB GBGB0623381.1A patent/GB0623381D0/en not_active Ceased
-
2007
- 2007-11-12 WO PCT/EP2007/009767 patent/WO2008061647A1/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO2008061647A8 (en) | 2008-11-27 |
| WO2008061647A1 (en) | 2008-05-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB0611405D0 (en) | FKBP-L: A novel inhibitor of angiogenesis | |
| PT2094708E (en) | A pyrrolopyrazin as syk-kinase inhibitor | |
| PL2402317T3 (en) | DGAT inhibitor | |
| PL2361922T3 (en) | Intermediate to HCV-Nucleoside Inhibitors | |
| SI2295410T1 (en) | HDAC inhibitor | |
| GB0621607D0 (en) | Inhibitors of c-Met | |
| ZA200808639B (en) | Oxadiazolidinedione compound | |
| IL196067A0 (en) | New cxcr2 inhibitors | |
| ZA200810025B (en) | Cox-2 inhibitor | |
| GB0602778D0 (en) | Novel compound | |
| PL1988081T3 (en) | Binding inhibitor of sphingosine-1-phosphate | |
| EP2050036A4 (en) | Potentiation of antifungal compounds | |
| GB0619325D0 (en) | New compounds | |
| EP2000469A4 (en) | Acylaminopiperidine compound | |
| EP2036894A4 (en) | Aurora inhibitor | |
| GB0607096D0 (en) | Compound | |
| GB0623381D0 (en) | Use of a compound as VEGF inhibitor | |
| IL205299A0 (en) | Parp inhibitor compounds | |
| GB0604142D0 (en) | Compound | |
| GB0625826D0 (en) | New compounds | |
| GB0625827D0 (en) | New compounds | |
| AP2717A (en) | Mono-hydrochloric salts of an inhibitor of histonedeacetylase | |
| HU0600920D0 (en) | New compounds | |
| GB0618263D0 (en) | Compound | |
| TWI316060B (en) | Neuraminidase inhibitor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |